Clazakizumab

Source: Wikipedia, the free encyclopedia.
Clazakizumab
Humanized
TargetIL6
Clinical data
Other namesALD518, BMS-945429
Routes of
administration
infusion
ATC code
  • none
Legal status
Legal status
  • investigational
Identifiers
CAS Number
ChemSpider
  • none
UNII
KEGG
Chemical and physical data
FormulaC6426H9972N1724O2032S42
Molar mass145239.02 g·mol−1

Clazakizumab (formerly ALD518 and BMS-945429), an

dose-response effect.[2]

See also

  • Tocilizumab (Actemra) an anti-IL-6 receptor mAb
  • Anti-IL-6
    , other anti-interleukin-6 agents

References